Second Sight Medical (EYES) Momentum Continues Following Robust IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/9/2026
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Brent climbs $1 on uncertainty over end to Iran war
- Atlassian results seen as 'game changer' for AI kills software worries
- The Trade Desk hit by Wall St downgrades after disappointing Q2 results, outlook
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- S&P closes at record high as soft jobs report eases rate-hike concerns
- US suffers unexpected job losses in July, markets dial back rate hike expectations
- Atlassian results seen as 'game changer' for AI kills software worries
- Microsoft only US hyperscaler with positive free cash flow as AI capex bites
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Second Sight Medical (EYES) Sees Profit Taking after 162% Post-IPO Surge
November 21, 2014 10:25 AM ESTThis week's hot IPO for Second Sight Medical (NASDAQ: EYES) is giving some back today. After gaining 162% in it fist two days of trading, shares are down 9.5% to $21.35 today. The IPO priced at $9.
Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients
... MoreMarket Wrap: Housing Starts Lag in Oct.; Fed to Keep on Path Amid Global Concerns; Target Surprises in Q3
November 19, 2014 5:25 PM ESTMarket wrap for November 19th
End of the Day: S&P 500 down 3.1 to 2,048.72; Dow Jones down 2.1 to 17,685.73; Nasdaq down 26.7 to 4,675.71
* Privately-owned housing starts in October were at a seasonally adjusted annual rate of 1.009 million. (Consensus estimates were at 1.025 million.) This is 2.8 percent (±10.0%)* below the revised September estimate of 1.038 million, but is 7.8 percent (±8.7%)* above the October 2013 rate of 936,000. Privately-owned housing units authorized by building permits in October were at a seasonally adjusted annual rate of 1.08 million. This is 4.8 percent (±1.3%) above the revised September rate of 1.031 million and is 1.2 percent... More
Second Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage
November 19, 2014 12:50 PM ESTWhile off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.
... MoreSecond Sight Medical (EYES) IPO Immediately Halted on Opening Surge
November 19, 2014 12:09 PM ESTToday's IPO for Second Sight Medical (NASDAQ: EYES) was immediately halted upon opening for trading at $17 versus the IPO price of $9.
... MoreSecond Sight Medical (EYES) IPO Opens Sharply Higher
November 19, 2014 12:06 PM ESTToday's IPO for Second Sight Medical (NASDAQ: EYES) opened for trading at $17 after pricing 3,500,000 shares of common stock at a price of $9.00 per share, in-line with the expected pricing.
MDB Capital Group, LLC served as the sole underwriter in connection with the... More
